<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
<journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLoS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29261713</article-id>
<article-id pub-id-type="pmc">5736193</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0189618</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-33335</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Neurology</subject>
<subj-group>
<subject>Epilepsy</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Human Genetics</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Anatomy</subject>
<subj-group>
<subject>Cardiovascular Anatomy</subject>
<subj-group>
<subject>Heart</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Anatomy</subject>
<subj-group>
<subject>Cardiovascular Anatomy</subject>
<subj-group>
<subject>Heart</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and life sciences</subject>
<subj-group>
<subject>Molecular biology</subject>
<subj-group>
<subject>Molecular biology techniques</subject>
<subj-group>
<subject>Sequencing techniques</subject>
<subj-group>
<subject>DNA sequencing</subject>
<subj-group>
<subject>Next-Generation Sequencing</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and analysis methods</subject>
<subj-group>
<subject>Molecular biology techniques</subject>
<subj-group>
<subject>Sequencing techniques</subject>
<subj-group>
<subject>DNA sequencing</subject>
<subj-group>
<subject>Next-Generation Sequencing</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Computational Biology</subject>
<subj-group>
<subject>Genome Analysis</subject>
<subj-group>
<subject>Transcriptome Analysis</subject>
<subj-group>
<subject>Next-Generation Sequencing</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genomics</subject>
<subj-group>
<subject>Genome Analysis</subject>
<subj-group>
<subject>Transcriptome Analysis</subject>
<subj-group>
<subject>Next-Generation Sequencing</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Biophysics</subject>
<subj-group>
<subject>Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Physical Sciences</subject>
<subj-group>
<subject>Physics</subject>
<subj-group>
<subject>Biophysics</subject>
<subj-group>
<subject>Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Physiology</subject>
<subj-group>
<subject>Electrophysiology</subject>
<subj-group>
<subject>Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Physiology</subject>
<subj-group>
<subject>Electrophysiology</subject>
<subj-group>
<subject>Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Physiology</subject>
<subj-group>
<subject>Electrophysiology</subject>
<subj-group>
<subject>Neurophysiology</subject>
<subj-group>
<subject>Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Physiology</subject>
<subj-group>
<subject>Electrophysiology</subject>
<subj-group>
<subject>Neurophysiology</subject>
<subj-group>
<subject>Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
<subj-group>
<subject>Neurophysiology</subject>
<subj-group>
<subject>Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Biochemistry</subject>
<subj-group>
<subject>Proteins</subject>
<subj-group>
<subject>Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Pathology and Laboratory Medicine</subject>
<subj-group>
<subject>Pathogens</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Clinical Genetics</subject>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Computational Biology</subject>
<subj-group>
<subject>Genome Analysis</subject>
<subj-group>
<subject>Genomic Libraries</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genomics</subject>
<subj-group>
<subject>Genome Analysis</subject>
<subj-group>
<subject>Genomic Libraries</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Targeted next-generation sequencing provides novel clues for associated epilepsy and cardiac conduction disorder/SUDEP</article-title>
<alt-title alt-title-type="running-head">NGS as genetic diagnosis tool for associated epilepsy and cardiac conduction disorder/SUDEP</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1214-803X</contrib-id>
<name>
<surname>Coll</surname>
<given-names>Monica</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Striano</surname>
<given-names>Pasquale</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferrer-Costa</surname>
<given-names>Carles</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5298-5276</contrib-id>
<name>
<surname>Campuzano</surname>
<given-names>Oscar</given-names>
</name>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3822-745X</contrib-id>
<name>
<surname>Matés</surname>
<given-names>Jesús</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Software</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>del Olmo</surname>
<given-names>Bernat</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Software</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iglesias</surname>
<given-names>Anna</given-names>
</name>
<role content-type="http://credit.casrai.org/">Project administration</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pérez-Serra</surname>
<given-names>Alexandra</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mademont</surname>
<given-names>Irene</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Picó</surname>
<given-names>Ferran</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oliva</surname>
<given-names>Antonio</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff006">
<sup>6</sup>
</xref>
<xref ref-type="author-notes" rid="econtrib001">
<sup>‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brugada</surname>
<given-names>Ramon</given-names>
</name>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff007">
<sup>7</sup>
</xref>
<xref ref-type="author-notes" rid="econtrib001">
<sup>‡</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label>
<addr-line>Cardiovascular Genetics Center, IDIBGI, Dr. Trueta University Hospital, Parc Hospitalari Martí i Julià, Edifici, Salt (Spain)</addr-line></aff>
<aff id="aff002"><label>2</label>
<addr-line>Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, "G. Gaslini" Institute, Genova (Italy)</addr-line></aff>
<aff id="aff003"><label>3</label>
<addr-line>Gendiag SL, Barcelona (Spain)</addr-line></aff>
<aff id="aff004"><label>4</label>
<addr-line>Department of Medical Sciences, School of medicine, University of Girona, Girona (Spain)</addr-line></aff>
<aff id="aff005"><label>5</label>
<addr-line>Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid (Spain)</addr-line></aff>
<aff id="aff006"><label>6</label>
<addr-line>Institute of Public Health, Section of Legal Medicine, Catholic University, Rome (Italy)</addr-line></aff>
<aff id="aff007"><label>7</label>
<addr-line>Cardiac Genetics Unit, Cardiology Service, Hospital Josep Trueta, Girona (Spain)</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Ai</surname>
<given-names>Tomohiko</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"></xref>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>Indiana University, UNITED STATES</addr-line>
</aff>
<author-notes>
<fn fn-type="COI-statement" id="coi001">
<p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</p>
</fn>
<fn fn-type="other" id="econtrib001">
<p>‡ These authors are co-senior authors on this work.</p>
</fn>
<corresp id="cor001">* E-mail: <email>mcoll@gencardio.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>12</issue>
<elocation-id>e0189618</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 Coll et al</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Coll et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="pone.0189618.pdf"></self-uri>
<abstract>
<p>Sudden unexpected death in epilepsy is an unpredicted condition in patients with a diagnosis of epilepsy, and autopsy does not conclusively identify cause of death. Although the pathophysiological mechanisms that underlie this entity remain unknown, the fact that epilepsy can affect cardiac function is not surprising. The genetic factors involving ion channels co-expressed in the heart and brain and other candidate genes have been previously described. In the present study, 20 epilepsy patients with personal or family history of heart rhythm disturbance/cardiac arrhythmias/sudden death were sequenced using a custom re-sequencing panel. Twenty-six relatives were genetically analysed to ascertain the family segregation in ten individuals. Four subjects revealed variants with positive genotype-phenotype segregation: four missense variants in the <italic>CDKL5</italic>, <italic>CNTNAP2</italic>, <italic>GRIN2A</italic> and <italic>ADGRV1</italic> genes and one copy number variant in <italic>KCNQ1</italic>. The potential pathogenic role of variants in new candidate genes will need further studies in larger cohorts, and the evaluation of the potential pathogenic role in the cardio-cerebral mechanisms requires in vivo/in vitro studies. In addition to family segregation, evaluation of the potential pathogenic roles of these variants in cardio-cerebral mechanisms by in vivo/in vitro studies should also be performed. The potential pathogenic role of variants in new candidate genes will need further studies in larger cohorts.</p>
</abstract>
<funding-group>
<funding-statement>The authors received no specific funding for this work. The funder provided support in the form of salaries for authors [C.F-C], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="2"></table-count>
<page-count count="16"></page-count>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<title>Data Availability</title>
<p>All relevant data are within the paper and its Supporting Information files.</p>
</notes>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Sudden unexpected death (SUDEP) is the sudden, unexpected, witnessed or unwitnessed, non-traumatic, and non-drowning death in patients with epilepsy, with or without evidence of a seizure, with exclusion of documented status epilepticus, and no conclusive cause of death after a comprehensive medico-legal autopsy[<xref ref-type="bibr" rid="pone.0189618.ref001">1</xref>]. SUDEP is the most common cause of death in individuals with epilepsy and accounts for 7.5–17% of all deaths[<xref ref-type="bibr" rid="pone.0189618.ref002">2</xref>]. Nevertheless, the incidence of SUDEP varies widely due to the heterogeneity of the studies (type of epilepsy, size of studied cohort, definition of SUDEP and how the cause of death was determined)[<xref ref-type="bibr" rid="pone.0189618.ref003">3</xref>]. The risk of SUDEP is higher in males than in females; however, other risk factors, such as frequency of tonic-clonic seizures, early age of onset of epilepsy and polytherapy with antiepileptic drugs, have been identified as risk factors[<xref ref-type="bibr" rid="pone.0189618.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0189618.ref004">4</xref>]. The pathophysiological mechanisms of SUDEP are likely multifactorial, but it has been suggested that a specific genetic background may predispose these patients to potentially fatal cardiorespiratory dysfunctions[<xref ref-type="bibr" rid="pone.0189618.ref003">3</xref>]. Indeed, seizures may induce a variety of transient cardiac effects, which include arrhythmias, asystole and other heart abnormalities, some of which are potentially lethal[<xref ref-type="bibr" rid="pone.0189618.ref003">3</xref>]. As pathogenic abnormalities in genes co-expressed in the heart and in the brain may eventually result in SUDEP, several studies have described pathogenic alterations in genes encoding ion channels in patients with concomitant heart conduction disorder and SUDEP[<xref ref-type="bibr" rid="pone.0189618.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0189618.ref006">6</xref>].</p>
<p>The advent of massive parallel DNA sequencing platforms, referred to as next-generation sequencing (NGS) technology, has revolutionized the field of medical genomics, enabling fast and cost-effective generation of genetic data. We previously performed a genetic study in a large cohort of individuals with epilepsy and cardiac conduction disorders and showed putative pathogenic disease-causing alterations in genes encoding cardiac ion channels in approximately 25% of unrelated individuals [<xref ref-type="bibr" rid="pone.0189618.ref007">7</xref>]. However, since SUDEP likely involves some combination of abnormal brain and cardiac physiology, certain additional gene categories, e.g., encoding for proteins with a key function of cell excitability, could be suitable candidates to explain the physiopathology of SUDEP [<xref ref-type="bibr" rid="pone.0189618.ref008">8</xref>].</p>
<p>To test this hypothesis, we used applied NGS analysis to a follow-up cohort of patients with epilepsy associated with cardiac conduction disorder/SUDEP.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>Genetic findings</title>
<p>Nineteen out of the 20 recruited patients carried 56 rare genetic variants in 37 genes. Among these genetic anomalies, only four variants, i.e., <italic>KCNQ1</italic>, <italic>KCNE1</italic>, <italic>SCN1A</italic>, and <italic>CACNA1C</italic>, were previously associated with SUDEP or other disorders associated with sudden cardiac death (SCD). We also identified 2 CNVs (<xref ref-type="fig" rid="pone.0189618.g001">Fig 1</xref>), 45 missense variants, 6 indels and 3 intronic variants (<xref ref-type="table" rid="pone.0189618.t001">Table 1</xref>).</p>
<fig id="pone.0189618.g001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189618.g001</object-id>
<label>Fig 1</label>
<caption>
<p>A: Deletion of exon 2 of the <italic>KCNQ1</italic> gene in ID#1. B: Duplication of exon 4 of the <italic>CNTNAP2</italic> gene in ID#15.</p>
</caption>
<graphic xlink:href="pone.0189618.g001"></graphic>
</fig>
<table-wrap id="pone.0189618.t001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189618.t001</object-id>
<label>Table 1</label>
<caption>
<title>Rare genetic variants identified in our cohort.</title>
</caption>
<alternatives>
<graphic id="pone.0189618.t001g" xlink:href="pone.0189618.t001"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Patient ID</th>
<th align="left" colspan="1" rowspan="1">Gene</th>
<th align="left" colspan="1" rowspan="1">Protein/cDNA variant</th>
<th align="left" colspan="1" rowspan="1">Variant Code</th>
<th align="left" colspan="1" rowspan="1">MAF (All)</th>
<th align="left" colspan="1" rowspan="1">
<italic>In silico</italic>
</th>
<th align="left" colspan="1" rowspan="1">Segregation</th>
<th align="left" colspan="1" rowspan="1">Pathogenicity Score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="8" rowspan="1">
<bold>Positive segregation</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="6">1<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNQ1</italic>
</td>
<td align="left" colspan="1" rowspan="1">exon 2 deletion</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>KCNE1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Arg98Trp (c.292C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs199473362, CM002283</td>
<td align="left" colspan="1" rowspan="1">1.653x10<sup>-5</sup></td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>HTR2A</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ile206Val (c.616A&gt;G)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">N/DC/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SENP2</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ser231Cysfs<xref ref-type="table-fn" rid="t001fn002">*</xref>43 (c.692-693delCT)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CDKL5</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Arg914Lys (c.2741G&gt;A<xref ref-type="table-fn" rid="t001fn002">*</xref>)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1H</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Thr78Ala (c.232A&gt;G)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">
<italic>CNTNAP2</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ser339Asn (c.1016G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">N/DC/DC</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4">3<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1">
<italic>GRIN2A</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Asn1076Lys (c.3228C&gt;A)</td>
<td align="left" colspan="1" rowspan="1">rs61758995</td>
<td align="left" colspan="1" rowspan="1">0.004349</td>
<td align="left" colspan="1" rowspan="1">PD/N/DC</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1A</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.His2216_His2217insHis (c.ins6646_6648insCAC)<break></break></td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">IP</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>ADSL</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Asp430Asn (c.1288G&gt;A)<break></break></td>
<td align="left" colspan="1" rowspan="1">rs554254383, CM001054</td>
<td align="left" colspan="1" rowspan="1">1.647x10<sup>-5</sup></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">IP</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>ADGRV1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Met1179Leu (c.3535A&gt;T)<break></break></td>
<td align="left" colspan="1" rowspan="1">rs759416461</td>
<td align="left" colspan="1" rowspan="1">8.292x10<sup>-6</sup></td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">IP</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">4<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1">
<italic>PLCB1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ala10Ser (c.28G&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs150241349</td>
<td align="left" colspan="1" rowspan="1">0.0003402</td>
<td align="left" colspan="1" rowspan="1">PD/N/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>ADGRV1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Glu3215Lys (c.9643G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">rs199499672</td>
<td align="left" colspan="1" rowspan="1">0.0003396</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="center" colspan="8" rowspan="1">
<bold>Incomplete penetrance</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">5<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1">
<italic>TSC1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ser108Phe (c.323C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">IP</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">
<italic>CELSR1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ala16_Ala17insAla (c.46_48insGCC)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNQ2</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Val450Met (c.1348G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">rs146492238</td>
<td align="left" colspan="1" rowspan="1">0.001265</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">IP</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<italic>HTR5A</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Pro95Leu (c.284C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs144847277</td>
<td align="left" colspan="1" rowspan="1">8.355x10-6</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<italic>SCN1A</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Arg1334Met (c.4001G&gt;T)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">IP</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1">
<italic>ADGRV1</italic>
<break></break>
</td>
<td align="left" colspan="1" rowspan="1">p.Arg4770His (c.14309G&gt;A)<break></break></td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">IP</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="6">8<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1">
<italic>BRD2</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ala599Pro (c.1795G&gt;C)</td>
<td align="left" colspan="1" rowspan="1">rs55952113</td>
<td align="left" colspan="1" rowspan="1">0.004153</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">IP</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>NRXN1</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1278+5A&gt;T</td>
<td align="left" colspan="1" rowspan="1">rs201802152</td>
<td align="left" colspan="1" rowspan="1">0.002269</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">IP</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SCARB2</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Glu93Lys (c.277G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">rs145870223</td>
<td align="left" colspan="1" rowspan="1">0.0001573</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>POLG</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Lys512Arg (c.1535A&gt;G)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>HTR3B</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ser156Arg (c.466A&gt;C)</td>
<td align="left" colspan="1" rowspan="1">rs72466469, CM083528</td>
<td align="left" colspan="1" rowspan="1">0.004127</td>
<td align="left" colspan="1" rowspan="1">PD/N/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SCN1A</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Arg1928Gly (c.5782C&gt;G)</td>
<td align="left" colspan="1" rowspan="1">rs121917956, CM081420</td>
<td align="left" colspan="1" rowspan="1">0.001427</td>
<td align="left" colspan="1" rowspan="1">B/N/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="center" colspan="8" rowspan="1">
<bold>No available relatives</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="5">9</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1H</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Met2312Val (c.6934A&gt;G)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">0.001677</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SLC2A1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Arg400Cys (c.1198C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>ADGRV1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Thr879Met (c.2636C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs201007778</td>
<td align="left" colspan="1" rowspan="1">0.0001631</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>MBD5</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Pro721Leu (c.2162C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs138639760</td>
<td align="left" colspan="1" rowspan="1">0.0001982</td>
<td align="left" colspan="1" rowspan="1">B/N/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SCN2A</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.605+3A&gt;G</td>
<td align="left" colspan="1" rowspan="1">rs778554811</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4">10</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1C</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Val1707Ile (c.5119G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">rs147896322</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">PD/N/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>HTR2A</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ala447Val (c.1340C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs6308, CM115490</td>
<td align="left" colspan="1" rowspan="1">0.001484</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>PNKP</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1029+2T&gt;C</td>
<td align="left" colspan="1" rowspan="1">rs199919568</td>
<td align="left" colspan="1" rowspan="1">0.0006509</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1I</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Asp2040Tyr (c.6118G&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs771105041</td>
<td align="left" colspan="1" rowspan="1">0.004771</td>
<td align="left" colspan="1" rowspan="1">PD/D/P</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">11</td>
<td align="left" colspan="1" rowspan="1">
<italic>HCN2</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.2143_2145delCCG</td>
<td align="left" colspan="1" rowspan="1">rs527536363</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1H</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ala1570Val (c.4709C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs558718048</td>
<td align="left" colspan="1" rowspan="1">5.014x10-5</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">12</td>
<td align="left" colspan="1" rowspan="1">
<italic>ADGRV1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Pro4181Leu (c.12542C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs200957385</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">B/D/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>KCNQ3</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Pro574Ser (c.1720C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs74582884, CM083709</td>
<td align="left" colspan="1" rowspan="1">0.001995</td>
<td align="left" colspan="1" rowspan="1">PD/N/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4">13</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1A</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.2319Gln_2320GlninsGln (c.6955_6957insCAG)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>BRD2</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Asn194Lys (c.582C&gt;G)</td>
<td align="left" colspan="1" rowspan="1">rs201572264</td>
<td align="left" colspan="1" rowspan="1">7.753x10-5</td>
<td align="left" colspan="1" rowspan="1">B/N/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>ADGRV1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Val754Ala (c.2261T&gt;C)</td>
<td align="left" colspan="1" rowspan="1">rs374609813</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">PD/N/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>HTR3B</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Gln334Glu (c.1001G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">rs199833563</td>
<td align="left" colspan="1" rowspan="1">8.238x10-6</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">14</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1A</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Gln2326_Gln2331del (c.6976_6993del18)</td>
<td align="left" colspan="1" rowspan="1">rs765169827</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SCARB2</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Val149Met (c.445G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">rs147159813</td>
<td align="left" colspan="1" rowspan="1">0.002053</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CNTNAP2</italic>
</td>
<td align="left" colspan="1" rowspan="1">exon 4 duplication</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">15</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1I</italic>
<break></break>
</td>
<td align="left" colspan="1" rowspan="1">p.Arg1448Gln (c.4343G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">rs201480163</td>
<td align="left" colspan="1" rowspan="1">9.944x10-5</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">16</td>
<td align="left" colspan="1" rowspan="1">
<italic>GRIN2B</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Lys1090Arg (c.3269A&gt;G)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>HTR7</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Lys445Asn (c.1335G&gt;C)</td>
<td align="left" colspan="1" rowspan="1">rs138700544</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CHRNB2</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Phe472Ser (c.1415T&gt;C)</td>
<td align="left" colspan="1" rowspan="1">rs200855905</td>
<td align="left" colspan="1" rowspan="1">4.118x10-5</td>
<td align="left" colspan="1" rowspan="1">PD/N/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">17</td>
<td align="left" colspan="1" rowspan="1">
<italic>ADGRV1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Glu2897Asp (c.8691A&gt;C)</td>
<td align="left" colspan="1" rowspan="1">rs201586455</td>
<td align="left" colspan="1" rowspan="1">0.004302</td>
<td align="left" colspan="1" rowspan="1">PD/N/DC</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
<tr>
<td align="center" colspan="8" rowspan="1">
<bold>No segregation</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">18</td>
<td align="left" colspan="1" rowspan="1">
<italic>TBC1D24</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Glu94Lys (c.280G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>ADSL</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Asp215Asn (c.643G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">PD/D/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>KCNMA1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Val792Ile (c.2374G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">rs142770262</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">B/N/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">19</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1H</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Ala2208Val (c.6623C&gt;T)</td>
<td align="left" colspan="1" rowspan="1">rs777217625</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">B/N/P</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<italic>EFHC1</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Arg42Pro (c.125G&gt;C)</td>
<td align="left" colspan="1" rowspan="1">rs773598517</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">B/N/DC</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">VUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<italic>ATP1A2</italic>
</td>
<td align="left" colspan="1" rowspan="1">p.Arg3His (c.8G&gt;A)</td>
<td align="left" colspan="1" rowspan="1">rs781687346</td>
<td align="left" colspan="1" rowspan="1">8.12x10-5</td>
<td align="left" colspan="1" rowspan="1">PD/N/P</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Likely non-pathogenic</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001">
<p>NA: DNA not available from relatives. IP: Incomplete penetrance. CM: Human gene variation database code. MAF: Minor allele frequency in the ExAG (Last consulted May 2016). <italic>In silico</italic> predictors were PolyPhen2, Provean and Mutation Taster. N: Neutral; D: Deleterious; P: Polymorphism; DC: Disease causing; B: Benign; PD: Possibly damaging; VUS: Variant of uncertain significance.</p>
</fn>
<fn id="t001fn002">
<p>*Variant detected in homozygous state.</p>
</fn>
<fn id="t001fn003">
<p><sup>a</sup>SUDEP cases sequenced in a previous custom resequencing panel.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>After the pathogenicity score classification, 3 variants were classified as likely pathogenic, 20 variants were classified as unknown significance, 21 variants were classified as likely non-pathogenic and 12 variants were classified as benign variants for no segregation within the family.</p>
<p>Segregation studies were performed in 10 out of 19 SUDEP cases, and a total of 26 relatives were genetically analysed to ascertain familiar segregation. Four cases showed at least one variant with positive segregation (ID#1–4), four cases with variants with incomplete penetrance pattern (ID#5–8) and two cases with negative segregation (ID#18–19). Four subjects, previously investigated with inconclusive results[<xref ref-type="bibr" rid="pone.0189618.ref009">9</xref>], showed positive segregation (individuals ID#1, ID#3 and ID#4) or an incomplete pattern of inheritance (ID#5).</p>
<p>Genetic variants in <italic>KCNQ1</italic> and <italic>CDKL5</italic> genes were identified in ID#1, who had family members affected by epilepsy and/or long QT syndrome (<xref ref-type="fig" rid="pone.0189618.g002">Fig 2A</xref>). While the exon 2 deletion in <italic>KCNQ1</italic> (<xref ref-type="fig" rid="pone.0189618.g001">Fig 1</xref>) showed complete segregation with the LQTS, it is unlikely that the <italic>CDKL5</italic> variant was causative of the observed epilepsy, as mutations related to this gene typically occur <italic>de novo</italic> and are associated with early-onset, severe, drug-refractory epileptic encephalopathy [<xref ref-type="bibr" rid="pone.0189618.ref010">10</xref>].</p>
<fig id="pone.0189618.g002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189618.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Pedigrees of the families with variants showing complete segregation (ID#1–4).</title>
</caption>
<graphic xlink:href="pone.0189618.g002"></graphic>
</fig>
<p>The variant in the <italic>CNTNAP2</italic> gene identified in individual ID# 2 is a novel change classified as a variant of unknown significance. Segregation studies showed that the non-affected sister (II:2) and their parents (I:1 and I:2) did not carry this variant (<xref ref-type="fig" rid="pone.0189618.g002">Fig 2B</xref>). Heterozygous mutations in <italic>CNTNAP2</italic> have been identified in patients with a range of complex phenotypes, including intellectual disability, autism and schizophrenia [<xref ref-type="bibr" rid="pone.0189618.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0189618.ref012">12</xref>]. However, heterozygous CNTNAP2 mutations are also found in the normal population, and it is likely that this variant alone does not fully explain the patient’s phenotype.</p>
<p>Patient #3 is a 24-year-old woman with family history (individual I:2) of SUDEP. However, her mother was not available for genetic analysis. Segregation analysis in the non-affected sisters (individuals II:2, II:3) and the father (subject I:1) was inconclusive (<xref ref-type="fig" rid="pone.0189618.g002">Fig 2C</xref>).</p>
<p>Individual ID#4 is a 52-year-old man with family history of epilepsy (sister) and sudden death (his brothers). The variant identified in <italic>ADGRV1</italic> is shared by the affected sister (II:2), but DNA for the deceased brothers was unavailable (<xref ref-type="fig" rid="pone.0189618.g002">Fig 2D</xref>).</p>
<p>Individual ID#5 is a 15-year-old boy carrying a novel variant in the <italic>TSC1</italic> gene. This variant was shared by his healthy father (II:3) and affected sister (III:2) with epileptic encephalopathy. There were antecedents of SCD from the paternal lineage, and the father’s cousins (III:1 and III:2) were affected by Brugada syndrome (<xref ref-type="fig" rid="pone.0189618.g003">Fig 3A</xref>).</p>
<fig id="pone.0189618.g003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189618.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Pedigrees of the families with variants showing an incomplete pattern of inheritance (ID#5–8).</title>
</caption>
<graphic xlink:href="pone.0189618.g003"></graphic>
</fig>
<p>Another case with IP was ID#6, a 9-year-old boy affected by SUDEP and Brugada syndrome. The non-affected mother (I:2) had family history of Brugada syndrome and showed the variants in <italic>KCNQ2</italic> and <italic>SCN1A</italic> genes. The variant in the <italic>SCN1A</italic> gene was also present in the non-asymptomatic sister (II:2) (<xref ref-type="fig" rid="pone.0189618.g003">Fig 3B</xref>).</p>
<p>ID#7 is a 16-year-old boy affected by focal epilepsy and LQTS and carrying a rare genetic variant in <italic>ADGRV1</italic> that was harboured by his healthy mother (I:2) (<xref ref-type="fig" rid="pone.0189618.g003">Fig 3C</xref>).</p>
<p>Finally, ID#8 is a 21-year-old girl who suffered focal epilepsy and SUDEP. She carried six rare genetic variants in <italic>BRD2</italic>, <italic>NRXN1</italic>, <italic>SCARB2</italic>, <italic>POLG</italic>, <italic>HTR3B</italic>, and <italic>SCN1A</italic>. The brother’s father (II:1) died from sudden death and the mother’s sister (II:4) experienced SUDEP. Her healthy mother (II:3) carried the variants in the <italic>BRD2</italic> and <italic>SCARB2</italic> genes. Thus, segregation analysis in this family was also inconclusive (<xref ref-type="fig" rid="pone.0189618.g003">Fig 3D</xref>).</p>
<p>There were two index cases with rare genetic variants not showing segregation with the pathology. ID#19 carried three variants in the <italic>ADSL</italic>, <italic>TBC1D24</italic>, and <italic>KCNMA1</italic> genes, but his dead brother (II:1) did not harbour any of these variants (<xref ref-type="fig" rid="pone.0189618.g004">Fig 4A</xref>). Patient ID#20 is a 12-year-old boy with focal epilepsy, and her brother (II:1) died of SUDEP while asleep at age 11 years. The maternal uncle has a 9-year-old child (II:3) who suffered a single seizure. Three rare genetic variants were identified in the index case, but only two of these variants (<italic>EFHC1</italic> and <italic>CACNA1H</italic>) were derived from the maternal lineage. However, these variants were absent in the deceased brother (II:2) (<xref ref-type="fig" rid="pone.0189618.g004">Fig 4B</xref>).</p>
<fig id="pone.0189618.g004" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189618.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Pedigree of the family with variants that did not show segregation (ID#18–19).</title>
</caption>
<graphic xlink:href="pone.0189618.g004"></graphic>
</fig>
</sec>
</sec>
<sec id="sec004" sec-type="conclusions">
<title>Discussion</title>
<p>Sudden unexpected death is a catastrophic complication of human epilepsy with an incidence of 6.3–9.3 per 1,000 person years in epilepsy patients entering surgery programmes [<xref ref-type="bibr" rid="pone.0189618.ref001">1</xref>]. Despite recent advances, both cellular mechanisms and genetic bases remain largely unknown.</p>
<p>A leading hypothesis suggests a dysfunction of excitability that could underlie both epilepsy and cardiac arrhythmias, leading to death [<xref ref-type="bibr" rid="pone.0189618.ref013">13</xref>]. Recently, there has been increased interest in the potential association between epilepsy channelopathies and cardiac arrhythmias [<xref ref-type="bibr" rid="pone.0189618.ref005">5</xref>–<xref ref-type="bibr" rid="pone.0189618.ref007">7</xref>]. NGS is a fast and cost-effective method for the simultaneous detection of single nucleotide variants (SNVs) and small insertions or deletions (indels). Various studies have employed massive sequencing technology to identify new potential genes responsible for SUDEP[<xref ref-type="bibr" rid="pone.0189618.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0189618.ref014">14</xref>]. Olson et al. identified several CNVs with causative roles in some cases of paediatric epilepsy, suggesting that these types of variations may potentially be associated with SUDEP cases[<xref ref-type="bibr" rid="pone.0189618.ref015">15</xref>]. We performed a comprehensive genetic analysis using NGS technology to further explore the role of already known and novel candidate genes associated with epilepsy/SUDEP.</p>
<p>The first index case (ID#1) evidenced the coexistence of both LQTS and epilepsy. The exon 2 deletion showed positive segregation with the LQTS and the mutation in the <italic>CDKL5</italic> gene with the epilepsy in this family. Deletions in <italic>KCNQ1</italic> exons were previously reported by NGS in individuals with LQTS [<xref ref-type="bibr" rid="pone.0189618.ref016">16</xref>]. The <italic>CDKL5</italic> gene acts as a kinase, and one of its target proteins is MeCP2, which plays important roles in the function of nerve cells (neurons) and other brain cells and in the maintenance of connections (synapses) between neurons. Pathogenic variants in the <italic>CDKL5</italic> gene have been associated with a disorder known as X-linked infantile spasm syndrome, which is characterized by recurrent seizures called infantile spasms that begin in the first year of life and with intellectual disability; however, it is not clear how mutations in this gene can result in this phenotype [<xref ref-type="bibr" rid="pone.0189618.ref010">10</xref>].</p>
<p>In ID#2 we detected a novel rare variant in the <italic>CNTNAP2</italic> gene (contactin associated protein-like 2). Pathogenic alterations in this gene were associated with cortical dysplasia focal epilepsy syndrome, a rare disorder resulting in epileptic seizures, language regression, intellectual disability, hyperactivity and autism in nearly two-thirds of the patients[<xref ref-type="bibr" rid="pone.0189618.ref011">11</xref>]. However, variants in this gene have been found in control populations, whereas homozygous variants are rare in patient populations and have not been found in any unaffected individuals[<xref ref-type="bibr" rid="pone.0189618.ref012">12</xref>]. Although the father was affected by Brugada syndrome (BrS) and epilepsy and carried this variant, the absence of this complex phenotype and the lack of expression of the <italic>CNTNAP2</italic> gene in the heart complicate the association between this variant and SUDEP.</p>
<p>Individual ID#3 carried four rare genetic variants, and only variants with positive segregation were detected in the <italic>GRIN2A</italic> gene, although pathogenic score classified as probably no-pathogenic variant. Mutations in this gene have been associated with focal epilepsies as the phenotype of our index case.</p>
<p>The variant with positive segregation in the ID#4 was identified in the <italic>ADGRV1</italic> gene also known as <italic>GPR98</italic> (<italic>MASS1</italic> gene). The encoded protein contains a 7-transmembrane receptor domain, binds calcium and was expressed in the central nervous system. Pathogenic alterations in this gene have been associated with recurrent febrile seizures and afebrile seizures[<xref ref-type="bibr" rid="pone.0189618.ref017">17</xref>].</p>
<p>The variant identified in the ID#5 was in <italic>TSC1</italic> gene, which encodes for hamartin, a protein that interacts with tuberin and helps to control cell growth and size through the mTOR pathway[<xref ref-type="bibr" rid="pone.0189618.ref018">18</xref>]. Mutations in this gene are responsible for Tuberous sclerosis complex (TSC) and focal cortical dysplasia associated with drug-resistant epilepsy. Although the proband does not have a phenotype compatible with TSC, the role of hamartin deserves additional investigation due to its high expression in heart muscle [<xref ref-type="bibr" rid="pone.0189618.ref019">19</xref>].</p>
<p>The <italic>KCNQ2</italic> variant identified in individual ID#6 and the non-affected mother belongs to a large family of genes encoding potassium channels associated with benign neonatal seizures [<xref ref-type="bibr" rid="pone.0189618.ref020">20</xref>], but the role of this variant in the BrS phenotype of this family remains unclear. Conversely, <italic>SCN1A</italic> is a good gene candidate associated with a large range of epileptic phenotypes as well as cardiac dysfunction [<xref ref-type="bibr" rid="pone.0189618.ref021">21</xref>].</p>
<p>The variant identified in the <italic>ADGRV1</italic> gene of ID#7 is present in the non-affected mother, and no family history of epilepsy or LQTS is known. Mutations in this gene have been associated with Usher’s syndrome and febrile seizures familiar 4 (FEB4) and was not expressed in the heart, indicating that this variant was more related to epilepsy than to LQTS in this family[<xref ref-type="bibr" rid="pone.0189618.ref022">22</xref>]. Genetic testing of the main and associated genes related to LQTS would be the next strategy to identify the genetic cause of the disease in this patient.</p>
<p>The last genes with IP with the diseases were detected in ID#8. The non-affected mother carried variants in the <italic>BRD2</italic> and <italic>SCARB2</italic> genes, which could explain the SUDEP in her sister. Mutations in both genes have been associated with myoclonic epilepsy[<xref ref-type="bibr" rid="pone.0189618.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0189618.ref024">24</xref>]. <italic>SCARB2</italic> gene encodes for LIMP-2 protein, which is found in the heart, specifically in the intercalated discs, although its precise function is not clear[<xref ref-type="bibr" rid="pone.0189618.ref022">22</xref>].</p>
<p>Pathogenic variants in the genes identified in the present cohort were previously associated with syndromes involving intellectual disabilities with episodes of seizures difficulty the possible relation with SUDEP. However, ion channel genes, such as calcium (<italic>GRIN2A)</italic>, potassium (<italic>KCNQ2</italic>) or sodium (<italic>SCN1A</italic>) channels, may represent interesting candidate genes that underlie SUDEP, as the expression and regulation of these genes contributes to the central control of cardiac and respiratory function.</p>
</sec>
<sec id="sec005" sec-type="conclusions">
<title>Conclusion</title>
<p>Rare genetic alterations in genes encoding brain/heart ion channels are responsible for epilepsy associated with cardiac conduction disorder/SUDEP. NGS technology enables the comprehensive cost-effectives genetic analysis of all current known genes as well as candidate genes. Overall, we identified 5 rare genetic variants that segregated within the pedigree and explain the cardiac conduction disorder/SUDEP. Only one variant was a previously described gene, revealing four new potential genes associated with this entity. The new custom re-sequencing panel enabled the identification of potential pathogenic variants in three out of four negative SUDEP cases in a previous study. Genetic data should be interpreted by a group of experts, and translation into clinical and forensic fields should be done with caution.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec007">
<title>Patients</title>
<p>The present study is a follow-up study in patients with clinical and EEG features consistent with a diagnosis of non-lesional (MRI-negative) focal or generalized epilepsy and a personal or family history of heart rhythm disturbances/cardiac arrhythmias/sudden death (<xref ref-type="table" rid="pone.0189618.t002">Table 2</xref>).</p>
<table-wrap id="pone.0189618.t002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189618.t002</object-id>
<label>Table 2</label>
<caption>
<title>Clinical data for the investigated cohort.</title>
</caption>
<alternatives>
<graphic id="pone.0189618.t002g" xlink:href="pone.0189618.t002"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="1">Proband ID</th>
<th align="center" colspan="1" rowspan="1">Age (y)</th>
<th align="center" colspan="1" rowspan="1">Gender</th>
<th align="center" colspan="1" rowspan="1">Epilepsy type (onset, y)</th>
<th align="center" colspan="1" rowspan="1">Cardiac comorbidity</th>
<th align="center" colspan="1" rowspan="1">Tested family members (n)</th>
<th align="center" colspan="1" rowspan="1">Segregating variant(s)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1">1</td>
<td align="center" colspan="1" rowspan="1">32</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (24)</td>
<td align="center" colspan="1" rowspan="1">LQTS</td>
<td align="center" colspan="1" rowspan="1">4</td>
<td align="center" colspan="1" rowspan="1">2/6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">2</td>
<td align="center" colspan="1" rowspan="1">31</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (21)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">3</td>
<td align="center" colspan="1" rowspan="1">1/1</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">3</td>
<td align="center" colspan="1" rowspan="1">24</td>
<td align="center" colspan="1" rowspan="1">Female</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (11)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">3</td>
<td align="center" colspan="1" rowspan="1">1/4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">4</td>
<td align="center" colspan="1" rowspan="1">52</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (43)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">1</td>
<td align="center" colspan="1" rowspan="1">1/2</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">5</td>
<td align="center" colspan="1" rowspan="1">15</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (7)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">3</td>
<td align="center" colspan="1" rowspan="1">0/1</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">6</td>
<td align="center" colspan="1" rowspan="1">9</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Generalized epilepsy (6)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">2</td>
<td align="center" colspan="1" rowspan="1">0/4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">7</td>
<td align="center" colspan="1" rowspan="1">16</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (11)</td>
<td align="center" colspan="1" rowspan="1">LQTS</td>
<td align="center" colspan="1" rowspan="1">2</td>
<td align="center" colspan="1" rowspan="1">0/1</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">8</td>
<td align="center" colspan="1" rowspan="1">21</td>
<td align="center" colspan="1" rowspan="1">Female</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (17)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">2</td>
<td align="center" colspan="1" rowspan="1">0/6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">9</td>
<td align="center" colspan="1" rowspan="1">13</td>
<td align="center" colspan="1" rowspan="1">Female</td>
<td align="center" colspan="1" rowspan="1">Generalized epilepsy (12)</td>
<td align="center" colspan="1" rowspan="1">CPVT</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">10</td>
<td align="center" colspan="1" rowspan="1">26</td>
<td align="center" colspan="1" rowspan="1">Female</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (26)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">11</td>
<td align="center" colspan="1" rowspan="1">22</td>
<td align="center" colspan="1" rowspan="1">Female</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (22)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">12</td>
<td align="center" colspan="1" rowspan="1">25</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Generalized epilepsy (14)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">13</td>
<td align="center" colspan="1" rowspan="1">21</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Generalized epilepsy (16)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">14</td>
<td align="center" colspan="1" rowspan="1">13</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Generalized epilepsy (12)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">15</td>
<td align="center" colspan="1" rowspan="1">19</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (17)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">16</td>
<td align="center" colspan="1" rowspan="1">23</td>
<td align="center" colspan="1" rowspan="1">Female</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (20)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">17</td>
<td align="center" colspan="1" rowspan="1">17</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Generalized epilepsy (14)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">18</td>
<td align="center" colspan="1" rowspan="1">23</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (20)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">3</td>
<td align="center" colspan="1" rowspan="1">0/3</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">19</td>
<td align="center" colspan="1" rowspan="1">12</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (10)</td>
<td align="center" colspan="1" rowspan="1">BS</td>
<td align="center" colspan="1" rowspan="1">3</td>
<td align="center" colspan="1" rowspan="1">0/3</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">20</td>
<td align="center" colspan="1" rowspan="1">12</td>
<td align="center" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">Focal epilepsy (8)</td>
<td align="center" colspan="1" rowspan="1">SUDEP</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001">
<p>NA: DNA not available from relatives. Familial individual tested excluding the proband. Variant/s segregated indicates the number of variants showing a complete segregation/total of the variants identified in the proband.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>DNA samples of relatives were obtained when available to ascertain the segregation of each genetic variant. All patients received at least one surface electrocardiogram (EKG), which was evaluated by an expert cardiologist. Vague histories of heart rhythm disturbances in family members not clearly known by the proband or with any available clinical/instrumental data were excluded.</p>
<p>Each proband was genetically evaluated by target re-sequencing of exonic and intron-exon boundary regions. Clinical data and DNA from available relatives were obtained for testing in segregation studies of the rare genetic variants. The four SUDEP cases included in this cohort were genetically negative in a previous published SUDEP study [<xref ref-type="bibr" rid="pone.0189618.ref009">9</xref>].</p>
<p>All individuals and their family members signed a written informed consent to participate in the present study in accordance with the guidelines of the International Review Board of Catholic University. The study was approved through the Ethics Committee of Catholic University (Rome, Italy) in accordance with the principles outlined in the Declaration of Helsinki. The Full name of Ethic Committee is “Ethics Commitee, Università Cattolica del Sacro Cuore Largo Agostino Gemelli 8, 00168 Roma, Italy. The individuals in the present study provided written informed consent (as outlined in PLOS consent form) to publish these case details.</p>
</sec>
<sec id="sec008">
<title>DNA samples</title>
<p>Genomic DNA was extracted from whole blood or saliva with Chemagic MSM I, and the concentration was checked by fluorometry (Qubit, Life Technologies). DNA integrity was assessed on a 0.8% agarose gel.</p>
</sec>
<sec id="sec009">
<title>NGS studies</title>
<p>We designed a custom resequencing panel, which included 122 genes associated with epilepsy as well as the main genes associated with cardiac channelopathies (<xref ref-type="supplementary-material" rid="pone.0189618.s001">S1 Table</xref>). The final size was 487.874 kbp of encoding regions and UTR boundaries. We targeted one isoform for each gene and only coding exons plus 10 bp inside intronic regions. Exons were obtained from ensembl site[<xref ref-type="bibr" rid="pone.0189618.ref025">25</xref>] version 81 in GRCh38 and translated to hg19. Bait design was achieved using an in-house algorithm and submitted to Agilent SureSelect Design Web. The chip design was achieved using variable tailing bait and variable multiplicity bait to obtain homogeneous coverage and optimize sample load. The present bait design algorithm considers the GC content of the bait itself, and the target and surrounding region of the targeted gene. This algorithm also considers multimapping of the bait regions and uses, when available, previous NGS results.</p>
<p>Genomic DNA was fragmented by sonication using the Bioruptor (Diagenode). The 122 genes were enriched using the SureSelect Custom Target Enrichment System Kit (Agilent Technologies, Santa Clara, CA USA) according to the manufacture’s instructions for the "SureSelect Target Enrichment System for Illumina Paired-End Sequencing version B.1” (SureSelect XT Custom 0–499 kbp library, Agilent Technologies, Inc.). The paired-end sequencing process was developed on a MiSeq System (Illumina) using 2x76 bp reads length.</p>
</sec>
<sec id="sec010">
<title>Data analysis</title>
<p>NGS analysis was submitted to the GendiCall Pipeline (Gendicall Software from FerrerIncode), which cleans up and trims fastq files from sequencer and then Gendicall maps using either GEM[<xref ref-type="bibr" rid="pone.0189618.ref026">26</xref>] or BWA mapper[<xref ref-type="bibr" rid="pone.0189618.ref027">27</xref>]. Subsequently, bam was generated and sorted, and duplicates were removed with Picard (<ext-link ext-link-type="uri" xlink:href="http://picard.sourceforge.net/">http://picard.sourceforge.net</ext-link>). Variant call for SNVs and Small Indels were performed using Samtools (v.1.3.1)[<xref ref-type="bibr" rid="pone.0189618.ref028">28</xref>] and internal Gendicall Caller. Annotation of called variants was based on several sources, and for population data, we used dbSNP[<xref ref-type="bibr" rid="pone.0189618.ref029">29</xref>], 1000 Genomes Project[<xref ref-type="bibr" rid="pone.0189618.ref030">30</xref>], Exome Variants Server (EVS)[<xref ref-type="bibr" rid="pone.0189618.ref031">31</xref>] and Exome Aggregation Consortium (ExAC) Cambridge, MA (URL: <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org</ext-link>). The protein predictors used in the present study were Polyphen2[<xref ref-type="bibr" rid="pone.0189618.ref032">32</xref>], Provean[<xref ref-type="bibr" rid="pone.0189618.ref033">33</xref>] and Mutation Taster[<xref ref-type="bibr" rid="pone.0189618.ref034">34</xref>]. Finally, we also used the splicing predictors MaxEntScan[<xref ref-type="bibr" rid="pone.0189618.ref035">35</xref>], FSPLICE[<xref ref-type="bibr" rid="pone.0189618.ref036">36</xref>], GeneSplicer[<xref ref-type="bibr" rid="pone.0189618.ref037">37</xref>] and NNsplice[<xref ref-type="bibr" rid="pone.0189618.ref038">38</xref>].</p>
</sec>
<sec id="sec011">
<title>Validation and bioinformatics analysis</title>
<p>The variants with MAF (minor allele frequency) lower than 0.1 (&lt;1%) were assessed in locus-specific databases that include dbSNP[<xref ref-type="bibr" rid="pone.0189618.ref029">29</xref>], Ensembl genome browser[<xref ref-type="bibr" rid="pone.0189618.ref025">25</xref>], the 1000 Genomes Project[<xref ref-type="bibr" rid="pone.0189618.ref039">39</xref>], EVS (Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA (URL: <ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>) [date (July, 2017) accessed] and ExAC[<xref ref-type="bibr" rid="pone.0189618.ref040">40</xref>]. Rare single nucleotide variants (SNPs) and insertions/deletions (indels) were confirmed by conventional Sanger sequencing, and copy number variants (CNVs) were confirmed by a multiplex ligation-dependent probe amplification (MLPA) technique.</p>
<p>Rare genetic variants and sequence regions with coverage lower than 30X were validated by the Sanger method. First, polymerase chain reaction (PCR) was performed, and the product was purified by ExoSAP-IT (USB Corporation, Cleveland, OH, USA) and directly sequenced by the dideoxy chain-termination method in ABI Prism Big Dye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, USA). Sequencing was processed in a 3130XL Genetic Analyzer (Applied Biosystems) and analysed by SeqScape Software v2.5 (Life Technologies), comparing the obtained results with the reference sequence from hg19. Protein numbering reflects the translation initiator methionine as +1.</p>
<p>The CNVs detected by NGS were confirmed by MLPA (MRC-Holland, Amsterdam, Netherlands) with the corresponding probe mix SALSA MLPA: SALSA MLPA P114 Long-QT probe mix and SALSA MLPA P297 Microdeletion Syndromes-2 probe mix. The MLPA DNA detection and quantification were performed according to the manufacturer’s protocol (MRC-Holland, Amsterdam, Netherlands). After the multiplex PCR reaction, electrophoresis was performed using the ABI3130xl Genetic Analyzer (Applied Biosystems, CA, USA), and the data were analysed with Coffalyser.net software (MRC-Holland). Significantly (30%) decreased or increased signals in the patient sample relative to controls were considered as deletions or duplications, respectively. Familial segregation of CNVs was also performed using MLPA. Variant frequencies (minor allele frequency, MAF&gt;1%) were obtained from the ExAC collection (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>).</p>
<p>A pathogenicity score was assigned to each variant for classification into the following categories: pathogenic, likely pathogenic, variant of unknown significance, likely non-pathogenic and benign, as described<italic>[<xref ref-type="bibr" rid="pone.0189618.ref041">41</xref>]</italic>. <italic>In silico</italic> analysis of the pathogenicity of rare nonsynonymous variants was performed by Polyphen2, Provean and MutationTaster [<xref ref-type="bibr" rid="pone.0189618.ref042">42</xref>–<xref ref-type="bibr" rid="pone.0189618.ref044">44</xref>].</p>
</sec>
</sec>
<sec id="sec012">
<title>Limitations</title>
<p>The present study has primary limitations. First, the lack of family segregation impedes the proper classification of the potential pathogenic role of each variant, and consequently, translation into clinical and forensic practice should be implemented with caution. In addition, functional in vivo/in vitro studies should also be performed to unravel the cellular mechanisms involved in SUDEP. We cannot exclude that these patients carry a genetic alteration in other genes that were not included in the present genetic panel. In these negative cases, and if the relatives are available, whole-exome sequencing studies could be a proper approach. Finally, additional studies in large cohorts should be performed to corroborate these results and identify new genetic alterations; however, the low incidence of SUDEP complicates sample collection.</p>
</sec>
<sec id="sec013" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="pone.0189618.s001">
<label>S1 Table</label>
<caption>
<title>List of genes included in the custom resequencing panel and the associated disease/s.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0189618.s001.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors received no specific funding for this work. The authors would like to thank the network of Genetic Commission of Italian League Against Epilepsy (LICE).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0189618.ref001">
<label>1</label>
<mixed-citation publication-type="journal"><name><surname>Nashef</surname><given-names>L</given-names></name>. <article-title>Sudden unexpected death in epilepsy: terminology and definitions</article-title>. <source/>Epilepsia. <year>1997</year>;<volume>38</volume>(<issue>11 Suppl</issue>):<fpage>S6</fpage>–<lpage>8</lpage>. Epub 1997/11/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1528-1157.1997.tb06130.x">10.1111/j.1528-1157.1997.tb06130.x</ext-link></comment> .<pub-id pub-id-type="pmid">19909329</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref002">
<label>2</label>
<mixed-citation publication-type="journal"><name><surname>Terra</surname><given-names>VC</given-names></name>. <article-title>Sudden unexpected death in epilepsy: From the lab to the clinic setting</article-title>. <source/>Epilsepy &amp; Behavior. <year>2012</year>.</mixed-citation>
</ref>
<ref id="pone.0189618.ref003">
<label>3</label>
<mixed-citation publication-type="journal"><name><surname>Dlouhy</surname><given-names>BJ</given-names></name>, <name><surname>Gehlbach</surname><given-names>BK</given-names></name>, <name><surname>Richerson</surname><given-names>GB</given-names></name>. <article-title>Sudden unexpected death in epilepsy: basic mechanisms and clinical implications for prevention</article-title>. <source/>Journal of neurology, neurosurgery, and psychiatry. <year>2016</year>;<volume>87</volume>(<issue>4</issue>):<fpage>402</fpage>–<lpage>13</lpage>. Epub 2016/03/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/jnnp-2013-307442">10.1136/jnnp-2013-307442</ext-link></comment> .<pub-id pub-id-type="pmid">26979537</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref004">
<label>4</label>
<mixed-citation publication-type="journal"><name><surname>Shorvon</surname><given-names>S</given-names></name>, <name><surname>Tomson</surname><given-names>T</given-names></name>. <article-title>Sudden unexpected death in epilepsy</article-title>. <source/>Lancet. <year>2011</year>;<volume>378</volume>(<issue>9808</issue>):<fpage>2028</fpage>–<lpage>38</lpage>. Epub 2011/07/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(11)60176-1">10.1016/S0140-6736(11)60176-1</ext-link></comment> .<pub-id pub-id-type="pmid">21737136</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref005">
<label>5</label>
<mixed-citation publication-type="journal"><name><surname>Partemi</surname><given-names>S</given-names></name>, <name><surname>Cestele</surname><given-names>S</given-names></name>, <name><surname>Pezzella</surname><given-names>M</given-names></name>, <name><surname>Campuzano</surname><given-names>O</given-names></name>, <name><surname>Paravidino</surname><given-names>R</given-names></name>, <name><surname>Pascali</surname><given-names>VL</given-names></name>, <etal>et al</etal>
<article-title>Loss-of-function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death</article-title>. <source/>Epilepsia. <year>2013</year>;<volume>54</volume>(<issue>8</issue>):<fpage>e112</fpage>–<lpage>6</lpage>. Epub 2013/08/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/epi.12259">10.1111/epi.12259</ext-link></comment> .<pub-id pub-id-type="pmid">23899126</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref006">
<label>6</label>
<mixed-citation publication-type="journal"><name><surname>Parisi</surname><given-names>P</given-names></name>, <name><surname>Oliva</surname><given-names>A</given-names></name>, <name><surname>Coll Vidal</surname><given-names>M</given-names></name>, <name><surname>Partemi</surname><given-names>S</given-names></name>, <name><surname>Campuzano</surname><given-names>O</given-names></name>, <name><surname>Iglesias</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Coexistence of epilepsy and Brugada syndrome in a family with SCN5A mutation</article-title>. <source/>Epilepsy research. <year>2013</year>;<volume>105</volume>(<issue>3</issue>):<fpage>415</fpage>–<lpage>8</lpage>. Epub 2013/03/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.eplepsyres.2013.02.024">10.1016/j.eplepsyres.2013.02.024</ext-link></comment> .<pub-id pub-id-type="pmid">23538271</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref007">
<label>7</label>
<mixed-citation publication-type="journal"><name><surname>Partemi</surname><given-names>S</given-names></name>, <name><surname>Vidal</surname><given-names>MC</given-names></name>, <name><surname>Striano</surname><given-names>P</given-names></name>, <name><surname>Campuzano</surname><given-names>O</given-names></name>, <name><surname>Allegue</surname><given-names>C</given-names></name>, <name><surname>Pezzella</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Genetic and forensic implications in epilepsy and cardiac arrhythmias: a case series</article-title>. <source/>International journal of legal medicine. <year>2014</year> Epub 2014/08/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00414-014-1063-4">10.1007/s00414-014-1063-4</ext-link></comment> .<pub-id pub-id-type="pmid">25119684</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref008">
<label>8</label>
<mixed-citation publication-type="journal"><name><surname>Glasscock</surname><given-names>E</given-names></name>. <article-title>Genomic biomarkers of SUDEP in brain and heart</article-title>. <source/>Epilepsy &amp; behavior: E&amp;B. <year>2013</year> Epub 2013/10/22. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.yebeh.2013.09.019">10.1016/j.yebeh.2013.09.019</ext-link></comment> .<pub-id pub-id-type="pmid">24139807</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref009">
<label>9</label>
<mixed-citation publication-type="journal"><name><surname>Coll</surname><given-names>M</given-names></name>, <name><surname>Allegue</surname><given-names>C</given-names></name>, <name><surname>Partemi</surname><given-names>S</given-names></name>, <name><surname>Mates</surname><given-names>J</given-names></name>, <name><surname>Del Olmo</surname><given-names>B</given-names></name>, <name><surname>Campuzano</surname><given-names>O</given-names></name>, <etal>et al</etal>
<article-title>Genetic investigation of sudden unexpected death in epilepsy cohort by panel target resequencing</article-title>. <source/>Int J Legal Med. <year>2016</year>;<volume>130</volume>(<issue>2</issue>):<fpage>331</fpage>–<lpage>9</lpage>. Epub 2015/10/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00414-015-1269-0">10.1007/s00414-015-1269-0</ext-link></comment> .<pub-id pub-id-type="pmid">26423924</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref010">
<label>10</label>
<mixed-citation publication-type="other"><ext-link ext-link-type="uri" xlink:href="https://ghr.nlm.nih.gov">https://ghr.nlm.nih.gov</ext-link>. Genetics Home ReferenceNational Library of Medicine (US). National Library of Medicine (US). 2016 June 07.</mixed-citation>
</ref>
<ref id="pone.0189618.ref011">
<label>11</label>
<mixed-citation publication-type="journal"><name><surname>Strauss</surname><given-names>KA</given-names></name>, <name><surname>Puffenberger</surname><given-names>EG</given-names></name>, <name><surname>Huentelman</surname><given-names>MJ</given-names></name>, <name><surname>Gottlieb</surname><given-names>S</given-names></name>, <name><surname>Dobrin</surname><given-names>SE</given-names></name>, <name><surname>Parod</surname><given-names>JM</given-names></name>, <etal>et al</etal>
<article-title>Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2</article-title>. <source/>N Engl J Med. <year>2006</year>;<volume>354</volume>(<issue>13</issue>):<fpage>1370</fpage>–<lpage>7</lpage>. Epub 2006/03/31. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa052773">10.1056/NEJMoa052773</ext-link></comment> .<pub-id pub-id-type="pmid">16571880</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref012">
<label>12</label>
<mixed-citation publication-type="journal"><name><surname>Rodenas-Cuadrado</surname><given-names>P</given-names></name>, <name><surname>Pietrafusa</surname><given-names>N</given-names></name>, <name><surname>Francavilla</surname><given-names>T</given-names></name>, <name><surname>La Neve</surname><given-names>A</given-names></name>, <name><surname>Striano</surname><given-names>P</given-names></name>, <name><surname>Vernes</surname><given-names>SC</given-names></name>. <article-title>Characterisation of CASPR2 deficiency disorder—a syndrome involving autism, epilepsy and language impairment</article-title>. <source/>BMC medical genetics. <year>2016</year>;<volume>17</volume>:<fpage>8</fpage> Epub 2016/02/05. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12881-016-0272-8">10.1186/s12881-016-0272-8</ext-link></comment> ; PubMed Central PMCID: PMC4739328.<pub-id pub-id-type="pmid">26843181</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref013">
<label>13</label>
<mixed-citation publication-type="journal"><name><surname>Devinsky</surname><given-names>O</given-names></name>, <name><surname>Hesdorffer</surname><given-names>DC</given-names></name>, <name><surname>Thurman</surname><given-names>DJ</given-names></name>, <name><surname>Lhatoo</surname><given-names>S</given-names></name>, <name><surname>Richerson</surname><given-names>G</given-names></name>. <article-title>Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention</article-title>. <source/>Lancet neurology. <year>2016</year>;<volume>15</volume>(<issue>10</issue>):<fpage>1075</fpage>–<lpage>88</lpage>. Epub 2016/08/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1474-4422(16)30158-2">10.1016/S1474-4422(16)30158-2</ext-link></comment> .<pub-id pub-id-type="pmid">27571159</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref014">
<label>14</label>
<mixed-citation publication-type="journal"><name><surname>Hata</surname><given-names>Y</given-names></name>, <name><surname>Yoshida</surname><given-names>K</given-names></name>, <name><surname>Kinoshita</surname><given-names>K</given-names></name>, <name><surname>Nishida</surname><given-names>N</given-names></name>. <article-title>Epilepsy-Related Sudden Unexpected Death: Targeted Molecular Analysis of Inherited Heart Disease Genes using Next-Generation DNA Sequencing</article-title>. <source/>Brain Pathol. <year>2016</year> Epub 2016/05/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bpa.12390">10.1111/bpa.12390</ext-link></comment> .<pub-id pub-id-type="pmid">27135274</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref015">
<label>15</label>
<mixed-citation publication-type="journal"><name><surname>Olson</surname><given-names>H</given-names></name>, <name><surname>Shen</surname><given-names>Y</given-names></name>, <name><surname>Avallone</surname><given-names>J</given-names></name>, <name><surname>Sheidley</surname><given-names>BR</given-names></name>, <name><surname>Pinsky</surname><given-names>R</given-names></name>, <name><surname>Bergin</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Copy number variation plays an important role in clinical epilepsy</article-title>. <source/>Ann Neurol. <year>2014</year>;<volume>75</volume>(<issue>6</issue>):<fpage>943</fpage>–<lpage>58</lpage>. Epub 2014/05/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ana.24178">10.1002/ana.24178</ext-link></comment> ; PubMed Central PMCID: PMC4487364.<pub-id pub-id-type="pmid">24811917</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref016">
<label>16</label>
<mixed-citation publication-type="journal"><name><surname>Campuzano</surname><given-names>O</given-names></name>, <name><surname>Sarquella-Brugada</surname><given-names>G</given-names></name>, <name><surname>Mademont-Soler</surname><given-names>I</given-names></name>, <name><surname>Allegue</surname><given-names>C</given-names></name>, <name><surname>Cesar</surname><given-names>S</given-names></name>, <name><surname>Ferrer-Costa</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Identification of Genetic Alterations, as Causative Genetic Defects in Long QT Syndrome, Using Next Generation Sequencing Technology</article-title>. <source/>PloS one. <year>2014</year>;<volume>9</volume>(<issue>12</issue>):<fpage>e114894</fpage> Epub 2014/12/11. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0114894">10.1371/journal.pone.0114894</ext-link></comment> ; PubMed Central PMCID: PMC4262446.<pub-id pub-id-type="pmid">25494010</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref017">
<label>17</label>
<mixed-citation publication-type="journal"><name><surname>Nakayama</surname><given-names>J</given-names></name>, <name><surname>Fu</surname><given-names>YH</given-names></name>, <name><surname>Clark</surname><given-names>AM</given-names></name>, <name><surname>Nakahara</surname><given-names>S</given-names></name>, <name><surname>Hamano</surname><given-names>K</given-names></name>, <name><surname>Iwasaki</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>A nonsense mutation of the MASS1 gene in a family with febrile and afebrile seizures</article-title>. <source/>Annals of neurology. <year>2002</year>;<volume>52</volume>(<issue>5</issue>):<fpage>654</fpage>–<lpage>7</lpage>. Epub 2002/10/29. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ana.10347">10.1002/ana.10347</ext-link></comment> .<pub-id pub-id-type="pmid">12402266</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref018">
<label>18</label>
<mixed-citation publication-type="journal"><name><surname>Striano</surname><given-names>P</given-names></name>, <name><surname>Zara</surname><given-names>F</given-names></name>. <article-title>Genetics: mutations in mTOR pathway linked to megalencephaly syndromes</article-title>. <source/>Nature reviews Neurology. <year>2012</year>;<volume>8</volume>(<issue>10</issue>):<fpage>542</fpage>–<lpage>4</lpage>. Epub 2012/08/22. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrneurol.2012.178">10.1038/nrneurol.2012.178</ext-link></comment> .<pub-id pub-id-type="pmid">22907262</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref019">
<label>19</label>
<mixed-citation publication-type="journal"><collab>The Genotype-Tissue Expression (GTEx) project</collab>. <source/>Nature genetics. <year>2013</year>;<volume>45</volume>(<issue>6</issue>):<fpage>580</fpage>–<lpage>5</lpage>. Epub 2013/05/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.2653">10.1038/ng.2653</ext-link></comment> ; PubMed Central PMCID: PMC4010069.<pub-id pub-id-type="pmid">23715323</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref020">
<label>20</label>
<mixed-citation publication-type="journal"><name><surname>Hortiguela</surname><given-names>M</given-names></name>, <name><surname>Fernandez-Marmiesse</surname><given-names>A</given-names></name>, <name><surname>Cantarin</surname><given-names>V</given-names></name>, <name><surname>Gouveia</surname><given-names>S</given-names></name>, <name><surname>Garcia-Penas</surname><given-names>JJ</given-names></name>, <name><surname>Fons</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Clinical and genetic features of 13 Spanish patients with KCNQ2 mutations</article-title>. <source/>Journal of human genetics. <year>2017</year>;<volume>62</volume>(<issue>2</issue>):<fpage>185</fpage>–<lpage>9</lpage>. Epub 2016/08/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jhg.2016.104">10.1038/jhg.2016.104</ext-link></comment> .<pub-id pub-id-type="pmid">27535030</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref021">
<label>21</label>
<mixed-citation publication-type="journal"><name><surname>Camfield</surname><given-names>P</given-names></name>, <name><surname>Camfield</surname><given-names>C</given-names></name>. <article-title>Febrile seizures and genetic epilepsy with febrile seizures plus (GEFS+)</article-title>. <source/>Epileptic disorders: international epilepsy journal with videotape. <year>2015</year>;<volume>17</volume>(<issue>2</issue>):<fpage>124</fpage>–<lpage>33</lpage>. Epub 2015/04/29. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1684/epd.2015.0737">10.1684/epd.2015.0737</ext-link></comment> .<pub-id pub-id-type="pmid">25917466</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref022">
<label>22</label>
<mixed-citation publication-type="other">Library GHRIBMT. Home page: National Library of Medicine (US). 2013 Sep 16</mixed-citation>
</ref>
<ref id="pone.0189618.ref023">
<label>23</label>
<mixed-citation publication-type="journal"><name><surname>Dibbens</surname><given-names>LM</given-names></name>, <name><surname>Michelucci</surname><given-names>R</given-names></name>, <name><surname>Gambardella</surname><given-names>A</given-names></name>, <name><surname>Andermann</surname><given-names>F</given-names></name>, <name><surname>Rubboli</surname><given-names>G</given-names></name>, <name><surname>Bayly</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure</article-title>. <source/>Annals of neurology. <year>2009</year>;<volume>66</volume>(<issue>4</issue>):<fpage>532</fpage>–<lpage>6</lpage>. Epub 2009/10/23. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ana.21765">10.1002/ana.21765</ext-link></comment> .<pub-id pub-id-type="pmid">19847901</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref024">
<label>24</label>
<mixed-citation publication-type="journal"><name><surname>Delgado-Escueta</surname><given-names>AV</given-names></name>, <name><surname>Koeleman</surname><given-names>BP</given-names></name>, <name><surname>Bailey</surname><given-names>JN</given-names></name>, <name><surname>Medina</surname><given-names>MT</given-names></name>, <name><surname>Duron</surname><given-names>RM</given-names></name>. <article-title>The quest for juvenile myoclonic epilepsy genes</article-title>. <source/>Epilepsy &amp; behavior: E&amp;B. <year>2013</year>;<volume>28</volume>
<issue>Suppl 1</issue>:<fpage>S52</fpage>–<lpage>7</lpage>. Epub 2013/06/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.yebeh.2012.06.033">10.1016/j.yebeh.2012.06.033</ext-link></comment> .<pub-id pub-id-type="pmid">23756480</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref025">
<label>25</label>
<mixed-citation publication-type="journal"><name><surname>Kersey</surname><given-names>PJ</given-names></name>, <name><surname>Staines</surname><given-names>DM</given-names></name>, <name><surname>Lawson</surname><given-names>D</given-names></name>, <name><surname>Kulesha</surname><given-names>E</given-names></name>, <name><surname>Derwent</surname><given-names>P</given-names></name>, <name><surname>Humphrey</surname><given-names>JC</given-names></name>, <etal>et al</etal>
<article-title>Ensembl Genomes: an integrative resource for genome-scale data from non-vertebrate species</article-title>. <source/>Nucleic acids research. <year>2012</year>;<volume>40</volume>(Database issue):<fpage>D91</fpage>–<lpage>7</lpage>. Epub 2011/11/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkr895">10.1093/nar/gkr895</ext-link></comment> ; PubMed Central PMCID: PMC3245118.<pub-id pub-id-type="pmid">22067447</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref026">
<label>26</label>
<mixed-citation publication-type="other">Napolitano C, Priori SG, Bloise R. Catecholaminergic Polymorphic Ventricular Tachycardia. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle (WA)1993.</mixed-citation>
</ref>
<ref id="pone.0189618.ref027">
<label>27</label>
<mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Durbin</surname><given-names>R</given-names></name>. <article-title>Fast and accurate long-read alignment with Burrows-Wheeler transform</article-title>. <source/>Bioinformatics. <year>2010</year>;<volume>26</volume>(<issue>5</issue>):<fpage>589</fpage>–<lpage>95</lpage>. Epub 2010/01/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btp698">10.1093/bioinformatics/btp698</ext-link></comment> ; PubMed Central PMCID: PMC2828108.<pub-id pub-id-type="pmid">20080505</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref028">
<label>28</label>
<mixed-citation publication-type="journal"><name><surname>Lodola</surname><given-names>F</given-names></name>, <name><surname>Morone</surname><given-names>D</given-names></name>, <name><surname>Denegri</surname><given-names>M</given-names></name>, <name><surname>Bongianino</surname><given-names>R</given-names></name>, <name><surname>Nakahama</surname><given-names>H</given-names></name>, <name><surname>Rutigliano</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Cell death &amp; disease. <year>2016</year>;<volume>7</volume>(<issue>10</issue>):<fpage>e2393</fpage> Epub 2016/10/07. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cddis.2016.304">10.1038/cddis.2016.304</ext-link></comment> ; PubMed Central PMCID: PMC5133973.<pub-id pub-id-type="pmid">27711080</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref029">
<label>29</label>
<mixed-citation publication-type="journal"><name><surname>Sherry</surname><given-names>ST</given-names></name>, <name><surname>Ward</surname><given-names>MH</given-names></name>, <name><surname>Kholodov</surname><given-names>M</given-names></name>, <name><surname>Baker</surname><given-names>J</given-names></name>, <name><surname>Phan</surname><given-names>L</given-names></name>, <name><surname>Smigielski</surname><given-names>EM</given-names></name>, <etal>et al</etal>
<article-title>dbSNP: the NCBI database of genetic variation</article-title>. <source/>Nucleic acids research. <year>2001</year>;<volume>29</volume>(<issue>1</issue>):<fpage>308</fpage>–<lpage>11</lpage>. Epub 2000/01/11. ; PubMed Central PMCID: PMC29783.<pub-id pub-id-type="pmid">11125122</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref030">
<label>30</label>
<mixed-citation publication-type="journal"><name><surname>Abecasis</surname><given-names>GR</given-names></name>, <name><surname>Auton</surname><given-names>A</given-names></name>, <name><surname>Brooks</surname><given-names>LD</given-names></name>, <name><surname>DePristo</surname><given-names>MA</given-names></name>, <name><surname>Durbin</surname><given-names>RM</given-names></name>, <name><surname>Handsaker</surname><given-names>RE</given-names></name>, <etal>et al</etal>
<article-title>An integrated map of genetic variation from 1,092 human genomes</article-title>. <source/>Nature. <year>2012</year>;<volume>491</volume>(<issue>7422</issue>):<fpage>56</fpage>–<lpage>65</lpage>. Epub 2012/11/07. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature11632">10.1038/nature11632</ext-link></comment> ; PubMed Central PMCID: PMC3498066.<pub-id pub-id-type="pmid">23128226</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref031">
<label>31</label>
<mixed-citation publication-type="other">Exome Variant Server NGESPE, Seattle, WA.</mixed-citation>
</ref>
<ref id="pone.0189618.ref032">
<label>32</label>
<mixed-citation publication-type="journal"><name><surname>Roston</surname><given-names>TM</given-names></name>, <name><surname>Guo</surname><given-names>W</given-names></name>, <name><surname>Krahn</surname><given-names>AD</given-names></name>, <name><surname>Wang</surname><given-names>R</given-names></name>, <name><surname>Van Petegem</surname><given-names>F</given-names></name>, <name><surname>Sanatani</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Journal of electrocardiology. <year>2017</year>;<volume>50</volume>(<issue>2</issue>):<fpage>227</fpage>–<lpage>33</lpage>. Epub 2016/09/21. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jelectrocard.2016.09.006">10.1016/j.jelectrocard.2016.09.006</ext-link></comment> .<pub-id pub-id-type="pmid">27646203</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref033">
<label>33</label>
<mixed-citation publication-type="journal"><name><surname>Ackerman</surname><given-names>MJ</given-names></name>, <name><surname>Priori</surname><given-names>SG</given-names></name>, <name><surname>Dubin</surname><given-names>AM</given-names></name>, <name><surname>Kowey</surname><given-names>P</given-names></name>, <name><surname>Linker</surname><given-names>NJ</given-names></name>, <name><surname>Slotwiner</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?</article-title>
<source/>Heart rhythm: the official journal of the Heart Rhythm Society. <year>2017</year>;<volume>14</volume>(<issue>1</issue>):<fpage>e41</fpage>–<lpage>e4</lpage>. Epub 2016/09/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.hrthm.2016.09.012">10.1016/j.hrthm.2016.09.012</ext-link></comment> .<pub-id pub-id-type="pmid">27659101</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref034">
<label>34</label>
<mixed-citation publication-type="journal"><name><surname>Willis</surname><given-names>BC</given-names></name>, <name><surname>Pandit</surname><given-names>SV</given-names></name>, <name><surname>Ponce-Balbuena</surname><given-names>D</given-names></name>, <name><surname>Zarzoso</surname><given-names>M</given-names></name>, <name><surname>Guerrero-Serna</surname><given-names>G</given-names></name>, <name><surname>Limbu</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Constitutive Intracellular Na+ Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia</article-title>. <source/>Circulation. <year>2016</year>;<volume>133</volume>(<issue>24</issue>):<fpage>2348</fpage>–<lpage>59</lpage>. Epub 2016/05/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.116.021936">10.1161/CIRCULATIONAHA.116.021936</ext-link></comment> ; PubMed Central PMCID: PMC4902321.<pub-id pub-id-type="pmid">27169737</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref035">
<label>35</label>
<mixed-citation publication-type="journal"><name><surname>Yeo</surname><given-names>G</given-names></name>, <name><surname>Burge</surname><given-names>CB</given-names></name>. <article-title>Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals</article-title>. <source/>Journal of computational biology: a journal of computational molecular cell biology. <year>2004</year>;<volume>11</volume>(<issue>2–3</issue>):<fpage>377</fpage>–<lpage>94</lpage>. Epub 2004/08/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/1066527041410418">10.1089/1066527041410418</ext-link></comment> .<pub-id pub-id-type="pmid">15285897</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref036">
<label>36</label>
<mixed-citation publication-type="journal"><name><surname>Desmet</surname><given-names>FO</given-names></name>, <name><surname>Hamroun</surname><given-names>D</given-names></name>, <name><surname>Lalande</surname><given-names>M</given-names></name>, <name><surname>Collod-Beroud</surname><given-names>G</given-names></name>, <name><surname>Claustres</surname><given-names>M</given-names></name>, <name><surname>Beroud</surname><given-names>C</given-names></name>. <article-title>Human Splicing Finder: an online bioinformatics tool to predict splicing signals</article-title>. <source/>Nucleic acids research. <year>2009</year>;<volume>37</volume>(<issue>9</issue>):<fpage>e67</fpage> Epub 2009/04/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkp215">10.1093/nar/gkp215</ext-link></comment> ; PubMed Central PMCID: PMC2685110.<pub-id pub-id-type="pmid">19339519</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref037">
<label>37</label>
<mixed-citation publication-type="journal"><name><surname>Pertea</surname><given-names>M</given-names></name>, <name><surname>Lin</surname><given-names>X</given-names></name>, <name><surname>Salzberg</surname><given-names>SL</given-names></name>. <article-title>GeneSplicer: a new computational method for splice site prediction</article-title>. <source/>Nucleic acids research. <year>2001</year>;<volume>29</volume>(<issue>5</issue>):<fpage>1185</fpage>–<lpage>90</lpage>. Epub 2001/02/27. ; PubMed Central PMCID: PMC29713.<pub-id pub-id-type="pmid">11222768</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref038">
<label>38</label>
<mixed-citation publication-type="journal"><name><surname>Reese</surname><given-names>MG</given-names></name>, <name><surname>Eeckman</surname><given-names>FH</given-names></name>, <name><surname>Kulp</surname><given-names>D</given-names></name>, <name><surname>Haussler</surname><given-names>D</given-names></name>. <article-title>Improved splice site detection in Genie</article-title>. <source/>Journal of computational biology: a journal of computational molecular cell biology. <year>1997</year>;<volume>4</volume>(<issue>3</issue>):<fpage>311</fpage>–<lpage>23</lpage>. Epub 1997/10/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/cmb.1997.4.311">10.1089/cmb.1997.4.311</ext-link></comment> .<pub-id pub-id-type="pmid">9278062</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref039">
<label>39</label>
<mixed-citation publication-type="journal"><name><surname>Auton</surname><given-names>A</given-names></name>, <name><surname>Brooks</surname><given-names>LD</given-names></name>, <name><surname>Durbin</surname><given-names>RM</given-names></name>, <name><surname>Garrison</surname><given-names>EP</given-names></name>, <name><surname>Kang</surname><given-names>HM</given-names></name>, <name><surname>Korbel</surname><given-names>JO</given-names></name>, <etal>et al</etal>
<article-title>A global reference for human genetic variation</article-title>. <source/>Nature. <year>2015</year>;<volume>526</volume>(<issue>7571</issue>):<fpage>68</fpage>–<lpage>74</lpage>. Epub 2015/10/04. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature15393">10.1038/nature15393</ext-link></comment> ; PubMed Central PMCID: PMC4750478.<pub-id pub-id-type="pmid">26432245</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref040">
<label>40</label>
<mixed-citation publication-type="journal"><name><surname>Lek</surname><given-names>M</given-names></name>, <name><surname>Karczewski</surname><given-names>KJ</given-names></name>, <name><surname>Minikel</surname><given-names>EV</given-names></name>, <name><surname>Samocha</surname><given-names>KE</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source/>Nature. <year>2016</year>;<volume>536</volume>(<issue>7616</issue>):<fpage>285</fpage>–<lpage>91</lpage>. Epub 2016/08/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature19057">10.1038/nature19057</ext-link></comment> ; PubMed Central PMCID: PMC5018207.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref041">
<label>41</label>
<mixed-citation publication-type="other">Campuzano O, Allegue, C., Fernández, A., Iglesias, A., Brugada, R. Determining the pathogenicity of genetic variants associated with cardiac channelopathies. Scientific reports. 2015;IN PRESS. 10.1038.</mixed-citation>
</ref>
<ref id="pone.0189618.ref042">
<label>42</label>
<mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>Y</given-names></name>, <name><surname>Sims</surname><given-names>GE</given-names></name>, <name><surname>Murphy</surname><given-names>S</given-names></name>, <name><surname>Miller</surname><given-names>JR</given-names></name>, <name><surname>Chan</surname><given-names>AP</given-names></name>. <article-title>Predicting the functional effect of amino acid substitutions and indels</article-title>. <source/>PloS one. <year>2012</year>;<volume>7</volume>(<issue>10</issue>):<fpage>e46688</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0046688">10.1371/journal.pone.0046688</ext-link></comment> ; PubMed Central PMCID: PMC3466303.<pub-id pub-id-type="pmid">23056405</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref043">
<label>43</label>
<mixed-citation publication-type="journal"><name><surname>Adzhubei</surname><given-names>IA</given-names></name>, <name><surname>Schmidt</surname><given-names>S</given-names></name>, <name><surname>Peshkin</surname><given-names>L</given-names></name>, <name><surname>Ramensky</surname><given-names>VE</given-names></name>, <name><surname>Gerasimova</surname><given-names>A</given-names></name>, <name><surname>Bork</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>A method and server for predicting damaging missense mutations</article-title>. <source/>Nature methods. <year>2010</year>;<volume>7</volume>(<issue>4</issue>):<fpage>248</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nmeth0410-248">10.1038/nmeth0410-248</ext-link></comment> ; PubMed Central PMCID: PMC2855889.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="pone.0189618.ref044">
<label>44</label>
<mixed-citation publication-type="journal"><name><surname>Schwarz</surname><given-names>JM</given-names></name>, <name><surname>Rodelsperger</surname><given-names>C</given-names></name>, <name><surname>Schuelke</surname><given-names>M</given-names></name>, <name><surname>Seelow</surname><given-names>D</given-names></name>. <article-title>MutationTaster evaluates disease-causing potential of sequence alterations</article-title>. <source/>Nature methods. <year>2010</year>;<volume>7</volume>(<issue>8</issue>):<fpage>575</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nmeth0810-575">10.1038/nmeth0810-575</ext-link></comment> .<pub-id pub-id-type="pmid">20676075</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>